Upregulation of vascular endothelial growth factor expression induced by myocardial ischaemia: implications for coronary angiogenesis.
about
Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tensionActivation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1A novel bHLH-PAS factor with close sequence similarity to hypoxia-inducible factor 1alpha regulates the VEGF expression and is potentially involved in lung and vascular developmentA Review of the Mechanisms of Blood-Brain Barrier Permeability by Tissue-Type Plasminogen Activator Treatment for Cerebral IschemiaIntermittent hypoxia: a low-risk research tool with therapeutic value in humansMRI tracking of FePro labeled fresh and cryopreserved long term in vitro expanded human cord blood AC133+ endothelial progenitor cells in rat gliomaNERF2, a member of the Ets family of transcription factors, is increased in response to hypoxia and angiopoietin-1: a potential mechanism for Tie2 regulation during hypoxiaVascular endothelial growth factor stimulates tyrosine phosphorylation and recruitment to new focal adhesions of focal adhesion kinase and paxillin in endothelial cellsHIF-1 alpha is required for solid tumor formation and embryonic vascularization.Coadministration of adenoviral vascular endothelial growth factor and angiopoietin-1 enhances vascularization and reduces ventricular remodeling in the infarcted myocardium of type 1 diabetic rats.Systemic hypoxia changes the organ-specific distribution of vascular endothelial growth factor and its receptorsCardiomyocyte-specific Estrogen Receptor Alpha Increases Angiogenesis, Lymphangiogenesis and Reduces Fibrosis in the Female Mouse Heart Post-Myocardial Infarction.Angiogenesis: new insights and therapeutic potential.Surviving ischemia: adaptive responses mediated by hypoxia-inducible factor 1Blood vessel repair and regeneration in the ischaemic heartFGF-1: a human growth factor in the induction of neoangiogenesis.VEGF antagonists.Restoration of blood flow by using continuous perimuscular infiltration of plasmid DNA encoding subterranean mole rat Spalax ehrenbergi VEGF.Evaluation of the fetal coronary circulation.Cardiac endothelial-myocardial signaling: its role in cardiac growth, contractile performance, and rhythmicity.Relative roles of direct regeneration versus paracrine effects of human cardiosphere-derived cells transplanted into infarcted mice.Induction of hypervascularity without leakage or inflammation in transgenic mice overexpressing hypoxia-inducible factor-1alpha.The emerging role of the thioredoxin system in angiogenesisRole of vascular permeability factor/vascular endothelial growth factor in eye disease.MiRNA and TF co-regulatory network analysis for the pathology and recurrence of myocardial infarctionActivation of growth hormone releasing hormone (GHRH) receptor stimulates cardiac reverse remodeling after myocardial infarction (MI)The CD154-CD40 T-cell co-stimulation pathway in liver ischemia and reperfusion inflammatory responses.Vascular endothelial growth factors VEGF-B and VEGF-C are expressed in human tumors.Expression of vascular endothelial growth factor in the human retina and in nonproliferative diabetic retinopathy.Stimulation of endothelial cell migration by vascular permeability factor/vascular endothelial growth factor through cooperative mechanisms involving the alphavbeta3 integrin, osteopontin, and thrombin.Hypoxia-induced vascular endothelial growth factor expression precedes neovascularization after cerebral ischemia.Hydrogen sulfide mitigates cardiac remodeling during myocardial infarction via improvement of angiogenesis.Easy-to-use strategy for reference gene selection in quantitative real-time PCR experiments.Morphological Plasticity of Emerging Purkinje Cells in Response to Exogenous VEGFEnhanced expression of vascular endothelial growth factor in metastatic melanomaPatterns of brain angiogenesis after vascular endothelial growth factor administration in vitro and in vivoIntracerebral tumor-associated hemorrhage caused by overexpression of the vascular endothelial growth factor isoforms VEGF121 and VEGF165 but not VEGF189Bevacizumab in the management of solid tumors.Exercise training and peripheral arterial disease.Regulation of vascular endothelial growth factor (VEGF) gene transcription by estrogen receptors alpha and beta
P2860
Q24307473-56EFB21C-5657-417D-A094-53F1732C7453Q24316075-CE80C37C-5609-4791-8E5C-7C414C4DEB18Q24681396-A2588C21-DB9C-4B3A-AA69-2E9EA9C8B5E4Q26772837-0E6D1AA8-BB6D-488A-8F54-6C2676262C19Q26824915-57707D7E-CE91-4B13-89D5-93E8821B0C0BQ27302331-F95A7EBA-68AB-4217-8703-CA635A11CB17Q28215504-8CB7B2EB-E9D2-4795-ABDC-C73F63655146Q28240564-F65EE7DD-A3BB-4659-A62B-61D03B607A80Q28588778-CCEFA37A-B246-48CD-BEDB-CA32F46FDFB5Q33556657-EE3C3423-D238-4037-99BB-D684A7102C3AQ33615441-05569191-DDC3-473C-B4CC-6914BA58726AQ33803183-4814DE69-3938-4486-B3AD-6397B85E6DDDQ33950625-12825601-D1F1-4699-892C-97DE5B3456E0Q34052670-6046FC95-C5D7-4DDB-9FF6-EA5DD65CDA05Q34304413-2C1358F4-F087-4028-A71C-F65D0C8109DFQ34430385-C77B569E-EE2C-43B5-B425-7A0DF2901FE3Q34451927-5A358E1E-1975-4CE5-82E7-98350A624BC2Q34959073-142FBEE6-8102-478B-A0A0-D79A371A31DCQ34970123-9118D90C-C541-4D0C-950F-69B46E0FCD62Q35035923-4A221B44-76DE-4F55-802A-828A451AB15FQ35050037-D6ECBCB1-3AA0-4CA0-B702-130C0B62E653Q35081587-7CE9508E-E3A7-4C5C-868F-D6F498F0FE7BQ35123800-EEC9FE0D-DA46-4A12-B22C-3CD3D882010CQ35300661-ACDD73DD-24B5-4CF2-89F4-F02EF9F2B7E2Q35386890-290089BA-FEAD-4322-A15A-02CBB0CE2BA2Q35673689-B1AAF506-F84E-4EA9-B4DB-35F1E2EB48CDQ35751635-BAECC8AF-F685-4471-86BC-BEF0A4F56E70Q35753219-DBE267B6-11C9-4B0D-95ED-AB834C5C59C3Q35765120-4C05AF8C-12D6-42E4-A491-490FDCA0101AQ35782323-30D3737A-115E-4EF3-B138-5AB3F6FDAFB7Q35809808-05652AD1-2E38-41D1-9E4D-EC8DAF8BC242Q35828530-CF7D00C2-79CF-4D9E-ADBB-9FFA579BFC6FQ36138944-A595AFFA-5D29-4971-B2DA-41A6376FF63AQ36279449-0CAB0BFF-F010-4453-AB46-2FC09ED6966AQ36431187-93BFAAF0-B525-4FCB-9512-E532B490193EQ36508351-E9D7DD87-7184-46F3-91AE-681333D3EAA1Q36636478-10E4120B-2C0E-4204-B410-FE306F8FC44CQ36788459-9B999FA1-2F64-4A00-A01E-954C8573CBF7Q37157213-46BC2E1D-2E88-4869-AB68-1DB3DE124148Q37268581-B6474724-57BC-4A42-A404-205FC00135F3
P2860
Upregulation of vascular endothelial growth factor expression induced by myocardial ischaemia: implications for coronary angiogenesis.
description
1994 nî lūn-bûn
@nan
1994 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
Upregulation of vascular endot ...... ons for coronary angiogenesis.
@ast
Upregulation of vascular endot ...... ons for coronary angiogenesis.
@en
Upregulation of vascular endot ...... ons for coronary angiogenesis.
@nl
type
label
Upregulation of vascular endot ...... ons for coronary angiogenesis.
@ast
Upregulation of vascular endot ...... ons for coronary angiogenesis.
@en
Upregulation of vascular endot ...... ons for coronary angiogenesis.
@nl
prefLabel
Upregulation of vascular endot ...... ons for coronary angiogenesis.
@ast
Upregulation of vascular endot ...... ons for coronary angiogenesis.
@en
Upregulation of vascular endot ...... ons for coronary angiogenesis.
@nl
P2093
P356
P1476
Upregulation of vascular endot ...... ons for coronary angiogenesis.
@en
P2093
P304
P356
10.1093/CVR/28.8.1176
P577
1994-08-01T00:00:00Z